FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound presented by formula 
, or their pharmaceutically acceptable salt, which can find application for treating or preventing ophthalmic diseases.
EFFECT: invention refers to the pharmaceutical compositions and methods of treating the ophthalmic diseases with the use of the above compound.
13 cl, 7 dwg, 7 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN | 2014 |
|
RU2669800C2 |
| TREATING CONDITIONS ASSOCIATED WITH HYPERINSULINEMIA | 2015 |
|
RU2722179C2 |
| COMPOSITIONS AND METHODS OF TREATING COLITIS | 2010 |
|
RU2518416C2 |
| METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT | 2007 |
|
RU2426542C2 |
| SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR MODULATORS AND USING THEM FOR TREATING MUSCULAR TISSUE INFLAMMATION | 2009 |
|
RU2521286C2 |
| NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
| LITHIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS | 2017 |
|
RU2765625C2 |
| THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
| SUBSTITUTED QUINOLINE DERIVATIVES AS MITOTIC KINESIN INHIBITORS | 2005 |
|
RU2385867C2 |
| METHOD FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 2017 |
|
RU2765737C2 |
